Type 1 diabetes
Our approach to partnering
We have nearly a century of expertise working with proteins and peptides. In recent years, we have increased our research technology platforms to include stem cells, RNA interference and genome editing. To realise the full potential of these research technologies, we are pioneering scientific innovation together with our external partners. This includes broadening our range of new collaborations, both within our current therapy areas, and in new disease areas and technologies.
Partnerships based on long-term commitment and mutual interest, and open innovation platforms that share knowledge and data, are key to creating a foundation for innovation.
From universities and biotech companies, to individual scientists and entrepreneurs, we are working globally towards our shared success.
Why collaborate with us?
We are proud to have a team of highly skilled scientists, as well as technical and commercial experts leading our partnering process. Learn more about our approach to partnering and let us know if you have any questions.
What we offer
In addition to being world-leaders in diabetes therapeutics, we are also constantly pursuing novel science and innovation in other areas of metabolic disease, and in several rare diseases. At Novo Nordisk, we take pride in our scientific, product development, and manufacturing core capabilities.
Learn more
We take pride in the way we work with our partners, and offer a collaborative mindset harnessed for sustainable and trust-based relationships, with bespoke engagement models and deal terms.
With our century-long heritage in diabetes and cardiometabolic disease, as well as our rare diseases expertise, we bring innovative medicines to the market to serve patients worldwide.
What we seek
- Pipeline partners with the complementary expertise needed to develop innovative products that address unmet medical needs in our areas of interest
- Commercial partners to make our products accessible to patients around the world
Hear from our partners
Great things in business are never achieved alone but by a team of people. From initiating first contact, through due diligence to signing and establishing the collaboration, it is about having the right people and competencies on both sides – to listen and learn.
Meet our partnering teams
Our highly skilled scientists and technology experts leading the partnering process are ready to hear from you.